1UICC. TNM classification of malignant tumours [S]. 5ed. New York:Wiley-Liss, 1997, 93-97.
2Aqudo A, Ahrens W, BenhanionE, et al. Lung cancer and cigarette smoking in womnen: a multicanter caase-control study in Europe [J]. Int J Canee, 2000, 88 (5): 820-827.
3Henschke CI, Yip R, Miettinen OS, et al. women' s susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer [J]. JAMA, 2006, 296 (2) : 180 - 184.
8Molerup S, Jorgensen K, Barge G, et al. expression of estrogen receptors alpha and beta in lung tissue and line [J]. Lung Cancer, 2002, 37 (2): 153 - 155.
9Taioli E, Wynder EL. Endocrine factors and adenocareinoma of the lung tn woman [J] . J Natl Cancer Inst, 1994, 86 (11): 869-870.
3[2]Kitawaki J,Obayashi H,Ishihara H,et al.Oestrogen receptor-alpha gene polymorphisms is associated with endometriosis,adenomyosis and leiomyomata.Hum Reprod,2001,16:51-55.
4[3]Hsien YY,Chang CC,Tsai FJ,et al.Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma.Fertil Steril,2003,79:96-99.
5[4]Massart F,Becherini L,Gennari L,et al.Genotype distribution of estrogen receptor alpha gene polymorphism in Italian women affected by surgical uterine leiomyomas.Fertil Steril,2001,75:567-570.
6[5]Massart F,Becherini L,Marinl F,et al.Analysis of estrogen receptor (EERα and Erβ) and progesterone receptor (PR) polymorphism in uterine leiomyomas.Med Sci Monit,2003,9:BR25-30.
7Tyczynski JE,Bray F,Aareleid T,et al.Lung cancer mortality patterns in selected Central,Eastern and Southern European countries[J].Int J Cancer,2004,109(4):598-610.
8Jemal A,Tiwari,Murray T,et al.Cancer Statistics,2004[J].CA Cancer J Clin,2004,54:8-29.
9Kexin C,Peizhong PW,Baocun S,et al.Twenty-year secular changes in sex specific lung cancer incidence rates in an urban Chinese population[J].Lung Cancer,2006,51(1):13-19.
10Mei-Lin L,Zhi-Wei C,Yin Z,et al.Study of incidences,time trends of long cancer,survivals and its predictive factor on shanghai population.[Abstract] 9th Annual Meeting of Chinese Society of Clinical Oncology,2006,9:5.
